Feasibility, tolerability, and efficacy of the concurrent addition of erlotinib to thoracic radiotherapy in locally advanced unresectable non-small-cell lung cancer: a Phase II trial

PURPOSE: Although many studies have confirmed the synergic effects of combining chemotherapy (CT) and radiotherapy (RT), clinical data evaluating safety and efficacy of erlotinib in combination with RT in locally advanced non-small-cell lung cancer (NSCLC) are limited. The aim of this study was to d...

Descripción completa

Detalles Bibliográficos
Autores principales: Martínez, Enrique, Martínez, Maite, Rico, Mikel, Hernández, Berta, Casas, Francesc, Viñolas, Nuria, Pérez-Casas, Ana, Dómine, Manuel, Mínguez, Julián
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780183/
https://www.ncbi.nlm.nih.gov/pubmed/27042098
http://dx.doi.org/10.2147/OTT.S89755

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780183/
https://www.ncbi.nlm.nih.gov/pubmed/27042098
http://dx.doi.org/10.2147/OTT.S89755

Ejemplares similares